TY - JOUR
T1 - Kronisk inflammatorisk demyeliniserende polyneuropati
AU - Markvardsen, Lars Kjøbsted
AU - Harbo, Thomas
AU - Holbech, Jakob Vormstrup
AU - Tankisi, Hatice
AU - Christiansen, Ingelise
AU - Olsen, Niels Kjær
AU - Jakobsen, Johannes
AU - Sindrup, Søren Hein
AU - Andersen, Henning
PY - 2019/7/22
Y1 - 2019/7/22
N2 - In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves. CIDP can be successfully treated with immunoglobulin, glucocorticoids or plasma exchange, and during the latest decade, immunoglobulin has been administered subcutaneously improving patients' flexibility and autonomy. By time, 30% of the patients will remit, and maintenance treatment will no longer be necessary.
AB - In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves. CIDP can be successfully treated with immunoglobulin, glucocorticoids or plasma exchange, and during the latest decade, immunoglobulin has been administered subcutaneously improving patients' flexibility and autonomy. By time, 30% of the patients will remit, and maintenance treatment will no longer be necessary.
UR - http://www.scopus.com/inward/record.url?scp=85070825725&partnerID=8YFLogxK
M3 - Tidsskriftartikel
C2 - 31364968
SN - 0041-5782
VL - 181
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
M1 - V02190079
ER -